Organovo Holdings, Inc. Organovo Holdings, Inc.

Organovo Holdings, Inc.

ONVO

Peringkat dalam Saham #36074
Organovo Holdings, Inc. is a biotechnology firm that specializes in engineering... Organovo Holdings, Inc. is a biotechnology firm that specializes in engineering sophisticated 3D tissues designed to accurately mimic critical facets of human diseases. Central to its operations is a comprehensive 3D human tissue platform, which features the company's proprietary NovoGen Bioprinters. These automated devices are crucial for fabricating complex, living 3D tissues from mammalian cells. The platform also includes supporting technologies necessary for creating specialized "bio-inks" and for the bioprinting of multi-cellular tissues with intricate structures. Organovo supplies specific products, such as ExVive human liver tissue and ExVive human kidney tissue, which are employed for predictive preclinical evaluation of investigational drug compounds. The company was founded in 2007 and maintains its corporate headquarters in Solana Beach, California.
Harga Saham
$2.00
Terakhir disinkronkan: 2025-05-19
Kapitalisasi Pasar
$2.93M
Perubahan (1 hari)
-3.38%
Perubahan (1 tahun)
656.14%
Negara
US
Perdagangan Organovo Holdings, Inc. (ONVO)

Kategori

Healthcare
Riwayat dividen untuk Organovo Holdings, Inc. (ONVO)
Saham Organovo Holdings, Inc. (simbol: ONVO) telah membayar total 0 dividen.
Total semua dividen (disesuaikan dengan stock split): 0.00
Imbal hasil dividen (TTM): 0
Pembayaran dividen untuk Organovo Holdings, Inc. (ONVO) dari 2026 hingga 2026
Pembayaran dividen tahunan
Tahun Dividen (disesuaikan dengan stock split) Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Daftar semua pembayaran dividen
Tahun Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Pembayaran dividen untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pembayaran dividen Negara
0.00%
US
0.00%
US
64.00%
AU
0.00%
CH
0.00%
NL